NCT02386605View on ClinicalTrials.gov

Motivational Negative Symptoms in Schizophrenia: Intervention and Biomarkers

NACompletedINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

March 28, 2016

Primary Completion Date

December 31, 2019

Study Completion Date

June 30, 2020

Conditions
SchizophreniaSchizoaffective Disorder
Interventions
BEHAVIORAL

Motivational Interviewing and Cognitive Behavioral Therapy

group-based recovery-oriented Motivational Interviewing combined with cognitive-behavioral therapy to target the negative symptoms of schizophrenia

BEHAVIORAL

Relaxation Skills

Relaxation and mindfulness skills training group for comparison condition for negative symptoms of schizophrenia

Trial Locations (1)

90073

VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT02386605 - Motivational Negative Symptoms in Schizophrenia: Intervention and Biomarkers | Biotech Hunter | Biotech Hunter